Gefitinib 250 mg Tablets Supplier From India

Indication: Gefitinib is indicated for the initial treatment of the adult patients with the non-small cell lung cancer (NSCLC) that is locally advanced (not suitable for a curative therapy) or metastatic (when cancerous cells have spread from the lung to the other organs of the body) who have activating mutations of the Epidermal Growth Factor Receptor tyrosine kinase (EGFR-TK).

Side Effects: The very common side effects are as follows:

• diarrhea

• nausea

• vomiting

• stomatitis

• loss of appetite

• rash

• itching dry skin

• cracked skin

• weakness

What dosage forms Gefitinib comes in: Geftinat is an oral tablet and each tablet contains 250 mg gefitinib. Geftinat comes in blister packs of 30 tablets.

Usual Dose: One 250 mg tablet should be consumed, once a day, every day, at the same time. You can take Geftinat either with or without food.

Manufactured By: Geftinat (Gefitinib tablets) is manufactured by Natco Pharma.

"IKRIS PHARMA NETWORK": A Reliable Supplier From India: IKRIS PHARMA NETWORK is an in demand pharmaceutical consultancy company legitimately known for their best as well as reliable service in order to provide access to genuine medications (such as Anticancer Medicines, Hepatitis C and Generic/Innovator drugs) through the dependable network of pharmaceutical distributors, suppliers and pharmacies.

The company is a step ahead as well as expertise in serving more than 150 nation's patients, so far.

Registered Office: 905, I Thum Business Park Plot No. A-40, Unit No. 5, Sector 62, Noida, Uttar Pradesh 201301.

WHO-GMP Certified: Ikris Pharma Network is an ISO 9001 2015 Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of Generic Gefitinib 250 mg (Geftinat).

Toll-free number +91 1800 889 1064

WhatsApp- +918130290915

Email –info@theindianpharma.com

Geftinat, a generic version of Gefitinib 250 mg is preferrelly supplied for Emergency imports, Tenders, Unlicensed, Specials, Name patient line, Orphan drug, RLD supplies, Comparator Drug, Reference listed drugs, Biosimilar, Innovator samples, and For Clinical trials.